Routine, recommended vaccines in the US currently offer some level of protection against 17 infectious diseases. One of these vaccines targets preteen boys and girls between 11 and 12 years of age—the human papillomavirus (HPV) vaccine. According to the 2017 Centers for Disease Control and Prevention (CDC) National Immunization Survey (NIS)-Teen, this vaccine is not widely used. Only 66% of boys and 67% of girls had received at least the first vaccine dose by age 15. Even fewer completed the full vaccine series of 2 to 3 doses—just 53% of girls and 48% of boys.
Read Safety Article
